Citadel Advisors’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $178K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $3.56M | Buy |
|
|||||
|
2024
Q3 | $2.12M | Hold |
|
|||||
|
2024
Q2 | $2.21M | Sell |
|
|||||
|
2024
Q1 | $4.52M | Buy |
|
|||||
|
2023
Q4 | $135K | Sell |
|
|||||
|
2023
Q3 | $2.47M | Buy |
|
|||||
|
2023
Q2 | $1.82M | Sell |
|
|||||
|
2023
Q1 | $6.53M | Buy |
|
|||||
|
2022
Q4 | $4.58M | Buy |
|
|||||
|
2022
Q3 | $119K | Buy |
|
|||||
|
2022
Q2 | $224K | Sell |
|
|||||
|
2022
Q1 | $1.25M | Buy |
|
|||||
|
2021
Q4 | $1.08M | Buy |
|
|||||
|
2021
Q3 | $583K | Buy |
|
|||||
|
2021
Q2 | $215K | Sell |
|
|||||
|
2021
Q1 | $3.08M | Sell |
|
|||||
|
2020
Q4 | $5.39M | Sell |
|
|||||
|
2020
Q3 | $5.96M | Buy |
|
|||||
|
2020
Q2 | $1.51M | Sell |
|
|||||
|
2020
Q1 | $3.17M | Buy |
|
|||||
|
2019
Q4 | $4.21M | Sell |
|
|||||
|
2019
Q3 | $9.08M | Buy |
|
|||||
|
2019
Q2 | $5.65M | Buy |
|
|||||
|
2019
Q1 | $609K | Buy |
|
|||||
|
2018
Q4 | – | Hold |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $209K | Sell |
|
|||||
|
2018
Q1 | $799K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $510K | Sell |
|
|||||
|
2017
Q1 | $1.31M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $279K | Buy |
|